Operating investor focused on scaling technology and SaaS businesses, Ethan Gilbert brings experience across growth-stage venture investing, corporate development and operator roles. He sources and diligences transactions, leads go-to-market optimization programs and works with CEOs on KPIs, unit economics and capital strategy. Prior roles span venture-backed startups and strategic investor teams. Active in deal sourcing and portfolio value creation, he is frequently engaged on board and advisory assignments.
Operating investor focused on scaling technology and SaaS businesses, Ethan Gilbert brings experience across growth-stage venture investing, corporate development and operator roles. He sources and diligences transactions, leads go-to-market optimization programs and works with CEOs on KPIs, unit economics and capital strategy. Prior roles span venture-backed startups and strategic investor teams. Active in deal sourcing and portfolio value creation, he is frequently engaged on board and advisory assignments.
Prefers concentrated, operator-oriented growth investments in technology and SaaS businesses where active intervention accelerates scale. Emphasizes rigorous unit-economics and KPI-driven diligence, prioritizing companies with clear go-to-market leverage, scalable gross margins and defensible customer acquisition dynamics. Capital deployment favors growth rounds and strategic follow-ons tied to milestone-based value creation plans. Time horizon is multi-year with a bias toward hands-on board and advisory engagement to de-risk execution and optimize exit readiness.
Prefers concentrated, operator-oriented growth investments in technology and SaaS businesses where active intervention accelerates scale. Emphasizes rigorous unit-economics and KPI-driven diligence, prioritizing companies with clear go-to-market leverage, scalable gross margins and defensible customer acquisition dynamics. Capital deployment favors growth rounds and strategic follow-ons tied to milestone-based value creation plans. Time horizon is multi-year with a bias toward hands-on board and advisory engagement to de-risk execution and optimize exit readiness.
| Trades 8099 | Longs Won 4550/8099 56% | Profit Factor 12.15 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $149,590.36 |
| Average Win $19,575.24 | Best Trade (Sep 08) $6.79M | Sharpe Ratio -9.9 |
| Average Loss -$2,065.67 | Worst Trade (Aug 19) -$588,673.6 | Z-Score 12.68 (100%) |
| Commissions $0 | Avg. Trade Length 9m 2d | Expectancy $10,092.15 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 250,000 | 225,000 | 200,000 | 175,000 | 150,000 | 125,000 | 100,000 | 75,000 | 50,000 | 25,000 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 26 | $3,061.18 | $4,050.28 | - | $989.1 | 32.31% | -0.358% |
AA Alcoa Corporation | 177 | $7,372.82 | $7,915.44 | - | $542.62 | 7.36% | -4.79% |
AAL American Airlines Group Inc. | 266 | $4,206.2 | $3,452.68 | - | -$753.52 | -17.91% | +0.309% |
AAOI Applied Optoelectronics, Inc. | 51 | $1,958.69 | $5,148.45 | - | $3,189.76 | 162.85% | +2.947% |
AAON Aaon Inc. | 7 | $617 | $532.91 | - | -$84.09 | -13.63% | -0.393% |
AAP Advance Auto Parts Inc. | 17 | $995.96 | $719.1 | - | -$276.86 | -27.8% | +0.762% |
AAPL Apple Inc. | 18,283 | $4.64M | $6.13M | - | $1.49M | 32.16% | -0.466% |
AAT American Assets Trust, Inc. | 27 | $534 | $591.97 | - | $57.97 | 10.86% | -0.926% |
ABAT American Battery Technology Company | 187 | $633.93 | $409.53 | - | -$224.4 | -35.4% | -2.232% |
ABBV AbbVie Inc. | 1,306 | $244,908.66 | $345,241.1 | - | $100,332.44 | 40.97% | +0.125% |
ABCB Ameris Bancorp | 39 | $2,822.24 | $3,242.85 | - | $420.61 | 14.9% | +0.181% |
ABG Asbury Automotive Group Inc. | 4 | $879.83 | $714.8 | - | -$165.03 | -18.76% | -4.901% |
ABM ABM Industries Inc. | 7 | $309.06 | $345.59 | - | $36.53 | 11.82% | +0.142% |
ABNB Airbnb, Inc. | 23 | $3,106.24 | $3,814.2 | - | $707.96 | 22.79% | -0.057% |
ABSI Absci Corporation | 2,044 | $5,355.28 | $19,346.46 | - | $13,991.18 | 261.26% | +2.104% |
ABT Abbott Laboratories | 1,175 | $140,571.65 | $120,854.62 | - | -$19,717.03 | -14.03% | +0.611% |
ABUS Arbutus Biopharma Corporation | 116 | $557 | $582.9 | - | $25.9 | 4.65% | -0.888% |
ACA Arcosa Inc. | 27 | $3,235.86 | $3,929.98 | - | $694.12 | 21.45% | +0.072% |
ACAD Acadia Pharmaceuticals Inc. | 10 | $248.64 | $269.65 | - | $21.01 | 8.45% | -1.767% |
ACDC ProFrac Holding Corp. | 86 | $500 | $437.74 | - | -$62.26 | -12.45% | +0.593% |